Company facts
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 540 filings
- On EDGAR
- CIK 1812364
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 25
News 8 of 63
Prospectuses and Registrations 8 of 26
- 424B5 Prospectus supplement for an offering Aug 6, 2026
- 424B5 Prospectus supplement for an offering May 21, 2026
- 424B5 Prospectus supplement for an offering May 19, 2026
- S-8 Registration statement for an employee plan Feb 26, 2026
- S-8 Registration statement for an employee plan Feb 26, 2025
- 424B5 Prospectus supplement for an offering Sep 11, 2024
- 424B5 Prospectus supplement for an offering Sep 9, 2024
- S-3ASR Automatic shelf registration Aug 6, 2024
Proxies 8 of 14
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- PRE 14A Preliminary proxy statement Apr 16, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2025
- DEFA14A Extra proxy material Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2024
- DEFA14A Extra proxy material Apr 21, 2023
Ownership 8 of 385
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 10, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 6, 2026
- 144 Notice of a proposed sale of restricted stock Aug 4, 2026
- 144 Notice of a proposed sale of restricted stock Jul 31, 2026
Other 8 of 27
Everything here comes from Relay Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.